Substance
DINUTUXIMAB
Global reference: every product and company linked to this substance.
- cas: 1363687-32-4
- ncit: C1570
- rxnorm: 1606274
- unii: 7SQY4ZUD30
APN-311 · APN311 · CH-14.18 · CH-14.18-UTC · CH-1418 · CH14.18 · CH14.18-UTC · CH1418 · dinutuximab [INN] · DINUTUXIMAB [JAN] · DINUTUXIMAB [USAN] · Dinutuximab [WHO-DD]
Revenue by product (1)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| UNITED THERAPEUTICS CORPORATION COMMON STOCK | UNITUXIN | Q2 2026 | $65.2M |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (1)
- UNITUXIN · UNITED THERAPEUTICS CORPORATION COMMON STOCK